Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma

Published Date: 09 Dec 2024

Two-thirds of phase II patients had a complete response at 12 weeks of treatment

Read Full News

Latest News

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Todays Updates

Abnormal Shadow on Chest Radiograph

Culture findings were key in making the diagnosis

Did Breast Cancer Radiation Cause This Weird Lung Problem?

Especially peculiar since the patient had no risk factors

Todays Updates

Abnormal Shadow on Chest Radiograph

Culture findings were key in making the diagnosis

Did Breast Cancer Radiation Cause This Weird Lung Problem?

Especially peculiar since the patient had no risk factors

Latest News

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

News, features, and commentary about cancer-related issues

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

News, features, and commentary about cancer-related issues

News All Time

Early Sugar Exposure and Cancer Risk; Melanoma Vaccine Win; 'Antifreeze' for CAR-T

News, features, and commentary about cancer-related issues

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

US Mental Health Treatment Rates Rise But Gaps Persist

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

Cognitive Bias Modification App Fosters Alcohol Avoidance

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Recommended News For You

Testosterone recovery linked to overall survival in high-risk prostate cancer

High levels of traumatic stress found in caregivers of adult cancer patients

Cancer deaths expected to rise to over 18 million in 2050, nearly 75% more than in 2024

Small Renal Mass Surveillance Does Not Affect Nephron-Sparing Surgery.

Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

Recommended Articles For You

Unraveling the Mysteries of Burkitt Lymphoma: A New Hope for Treatment 

Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health 

Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification 

Ticagrelor Monotherapy vs. Ticagrelor + Aspirin in ACS Post-PCI: ULTIMATE-DAPT Trial 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

2.

For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.

3.

Formaldehyde releasers found in common personal care products used especially by Black and Latina women

4.

AI catches one-third of interval breast cancers missed at screening

5.

For patients with breast cancer receiving chemotherapy, exercise may help lessen the long-term side effects.

1.

A Closer Look at the Effects of Sickle Cell on Eyesight

2.

Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role

3.

Ferroptosis-Modulating Therapeutics in Precision Oncology

4.

Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management

5.

Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

A New Era in Managing Cancer-Associated Thrombosis

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

4.

Navigating the Complexities of Ph Negative ALL - Part XVI

5.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot